Clinical Trial Update: Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Taurolock Hep 500 versus unfractionated heparin as an anti-inflammatory strategy for hemodialysis catheters; the trial status is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection
• Thrombosis

Drugs mentioned

• Taurolock Hep 500
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Ain Shams University | Conditions: Hemodialysis Catheter Infection, Thrombosis; Dialysis Catheter | Phase 4 | Status: UNKNOWN